Charles River Laboratories (CRL)

Currency in USD
177.33
+1.97(+1.12%)
Closed·
177.07-0.26(-0.15%)
·

CRL Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
3.12 / 2.50
Revenue / Forecast
1.03B / 984.86M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025--/2.34--/984.66M----Free Sign Up
06/20253.12/2.51.03B/984.86M+24.8%+4.58%Free Sign Up
03/20250.5/2.09984.17M/941.47M-76.08%+4.54%Free Sign Up
12/20242.66/2.541B/985.18M+4.72%+1.5%Free Sign Up
09/20242.59/2.421.01B/976M+7.02%+3.48%Free Sign Up
06/20242.8/2.41.03B/1.02B+16.67%+0.98%Free Sign Up
03/20242.27/2.061.01B/992.31M+10.19%+1.78%Free Sign Up
12/20232.46/2.411.01B/991.25M+2.07%+1.89%Free Sign Up
09/20232.72/2.361.03B/1B+15.25%+3%Free Sign Up
06/20232.69/2.641.06B/1.05B+1.89%+0.95%Free Sign Up

All numbers in USD

Charles River Laboratories Earnings Call Summary for Q2/2025

  • Charles River Labs Q2 2025 EPS of $3.12 beat forecasts by 24.8%, with revenue at $1.03B; stock fell 10.57% pre-market despite beat
  • Full-year EPS guidance raised to $9.90-$10.30; organic revenue decline of 1-3% projected for 2025 amid market challenges
  • CEO Jim Foster noted stabilizing demand and cautious hiring; company expects over $175M in cost savings for 2025
  • Expansion of New Approach Methods portfolio and focus on operational efficiencies highlighted as key strategic initiatives
  • Challenges include biotech funding constraints, forex fluctuations, and $10M headwind from DSA staffing in H2 2025
Last Updated: 19/08/2025, 03:10
Read Full Transcript

FAQ

What Is Charles River Laboratories's Earnings Per Share (TTM)?

The Charles River Laboratories EPS (TTM) is -1.37.

When Is The Next Charles River Laboratories Earnings Date?

Charles River Laboratories will release its next earnings report on 28 Oct 2025.

What Is Charles River Laboratories’s Revenue Forecasts For Upcoming Quarters?

Charles River Laboratories’s revenue forecast is 984.66M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.